Hechos relevantes

ALMIRALL, S.A.

desde 01/07/1988 hasta 11/06/2024

• • 06/11/2017
  • 08:00
  • ALMIRALL, S.A.
  • Information on P&L. - Announcements of public presentations and meetings
  • Almirall announces that a webcast with analysts and institutional investors will be held today at 10.00 am CET related to the Q3 2017 Financial Results.
  • Número de registro: 258228
• • 06/11/2017
  • 07:50
  • ALMIRALL, S.A.
  • Interim financial information
  • La sociedad remite información sobre los resultados del tercer trimestre de 2017
  • Número de registro: 258227
• • 31/10/2017
  • 18:05
  • ALMIRALL, S.A.
  • Others on business performance and financial information
  • Pipeline update
  • Número de registro: 258065
• • 29/09/2017
  • 09:02
  • ALMIRALL, S.A.
  • Others on business performance and financial information
  • Pipeline update
  • Número de registro: 256872
• • 28/08/2017
  • 18:29
  • ALMIRALL, S.A.
  • Composition of the board of directors. - Composition of other management and supervisory bodies
  • CEO succession in Almirall
  • Número de registro: 255964
• • 24/07/2017
  • 07:51
  • ALMIRALL, S.A.
  • Information on P&L. - Announcements of public presentations and meetings
  • Almirall announces that a webcast with analysts and institutional investors will be held today at 10.00 am CET related to the H1 2017 Financial Results. Please find attached the Press Release and the presentation for the Webcast.
  • Número de registro: 254862
• • 24/07/2017
  • 07:37
  • ALMIRALL, S.A.
  • Interim financial information
  • La sociedad remite información sobre los resultados del primer semestre de 2017
  • Número de registro: 254861
• • 10/07/2017
  • 06:29
  • ALMIRALL, S.A.
  • Information on P&L
  • Almirall: Guidance Update 2017
  • Número de registro: 254387
• • 27/06/2017
  • 07:59
  • ALMIRALL, S.A.
  • R&D: new licenses, patents and registered trademarks
  • European Commission (EC) approves Almirall’s Skilarence® for moderate-to-severe chronic plaque Psoriasis
  • Número de registro: 253865
• • 19/06/2017
  • 08:01
  • ALMIRALL, S.A.
  • Others on business performance and financial information
  • Almirall ready to react to introduction of generic to ActiclateTM in the US market
  • Número de registro: 253485